The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Antithyroid Drug-Induced Hematopoietic Damage: A Retrospective Cohort Study of Agranulocytosis and Pancytopenia Involving 50,385 Patients with Graves' Disease
Abstract
CONTEXT: Although antithyroid drug (ATD)-induced hematopoietic damage is a significant concern, it has not been comprehensively investigated. OBJECTIVE: Our objective was to describe the clinical features of ATD-induced hematopoietic damage. DESIGN AND SETTING: This was a retrospective cohort study in Tokyo, Japan. PATIENTS: Between January 1983 and December 2002, 50,385 patients at Ito Hospital were diagnosed with Graves' disease. We retrospectively reviewed their medical, pathological, and laboratory records between January 1983 and December 2010. MAIN OUTCOME: Incidence and clinical features of ATD-induced agranulocytosis and pancytopenia were evaluated. RESULTS: Of 55 patients with documented hematopoietic damage, 50 had agranulocytosis and 5 had pancytopenia. All of them received ATD, either methimazole (n = 51) or propylthiouracil (n = 4). Median intervals between initiation of ATD therapy and the onset of agranulocytosis and pancytopenia were 69 d (range, 11-233 d) and 41 d (range, 32-97 d), respectively. Either anemia or thrombocytopenia was also documented in seven of the 50 patients with agranulocytosis. Agranulocytosis was the first manifestation of hematopoietic damage in four of the five patents with pancytopenia. Hematopoietic damage recovered with supportive measures including granulocyte colony-stimulating factor (n = 37), steroids (n = 10), and other supportive measures (n = 8) in 54 patients, whereas the remaining patient died of complications from infection. This study failed to identify the risk factors for ATD-induced hematopoietic damage. CONCLUSIONS: This study showed that ATD cause hematopoietic changes, which are occasionally severe and potentially fatal. The pathogenesis of agranulocytosis and pancytopenia might overlap, and additional studies are warranted to clarify this and to establish an optimal treatment strategy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three recent reports of large numbers of ATD-treated patients who developed hematologic complications provide information on risk factors, treatment, and outcomes (127-129).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“Two studies were from Japan and one was from Denmark.In both countries the majority of patients are treated with MMI, so data are more limited for PTU-associated agranulocytosis.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“No predictive risk factors for the development of agranulocytosis could be identified.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“In the first study, a retrospective cohort analysis of over 50,000 GD patients, 55 developed agranulocytosis, of whom five had pancytopenia, for an estimated cumulative incidence of 0.3% in 100 days (127), with a median interval to onset of 69 days.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
In the citing paper
“All 50 patients with agranulocytosis alone were successfully treated with granulocyte colony stimulating factor, steroids, or supportive care, but one of five patients with pancytopenia died.”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeGroot, L. J., Abalovich, M., Alexander, E. K., Amino, N., Barbour, L. A., Cobin, R. H., Eastman, C. J., Lazarus, J. H., Luton, D., Mandel, S. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2803 · Cited by 1,885
Abalovich, M., Amino, N., Barbour, L. A., Cobin, R. H., DeGroot, L. J., Glinoer, D., Mandel, S. J., & Stagnaro‐Green, A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0141 · Cited by 934
Spontaneous reporting of adverse reactions to carbimazole and propylthiouracil in the UK
Pearce, S. H. S. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02135.x · Cited by 120
Fibbe, W. E., Claas, F. H. J., van der Star, W., Meyboom, R. H. B., Meyboom, R. H. B., & Falkenburg, J. H. F. (1986) · British Journal of Haematology · doi:10.1111/j.1365-2141.1986.tb04130.x · Cited by 100
Thyroid function in wholly breast‐feeding infants whose mothers take high doses of propylthiouracil
Momotani, N., Yamashita, R., Makino, F., Noh, J. Y., Ishikawa, N., Ito, K., & Ito, K. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01078.x · Cited by 94
Self-citationHaematopoietic growth factor in antithyroid-drug-induced agranulocytosis
Andrès, E. (2001) · QJM · doi:10.1093/qjmed/94.8.423 · Cited by 73
Akamizu, T., Ozaki, S., Hiratani, H., Uesugi, H., Sobajima, J., Hataya, Y., Kanamoto, N., Saijo, M., Hattori, Y., Moriyama, K., et al. (2002) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2002.01720.x · Cited by 58
Michallet, M., Sobh, M., Morisset, S., Kraghel, S., Nicolini, F. E., Thomas, X., Bienvenu, A., Picot, S., Nicolle, M., & Vanhems, P. (2011) · Medical Mycology · doi:10.3109/13693786.2011.557668 · Cited by 49
Aplastic Anemia Associated with Antithyroid Drugs
Biswas, N., Ahn, Y.-H., Goldman, J. M., & Schwartz, J. M. (1991) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199103000-00008 · Cited by 42
Escobar-Morreale, H. F., BRAVO, P., García‐Robles, R., García‐Laraña, J., de la Calle, H., & SANCHO, J. M. (1997) · Thyroid · doi:10.1089/thy.1997.7.67 · Cited by 32
Flagged first, then by citations
Research works printed but not linked: 1
- Solomon DH 1986 Treatment of Graves' hyperthyroidism. In: In- gbar SH, Braverman LE, eds. Werner's the thyroid. 5th ed. Phila- delphia: JB Lippincott; 987-1014
Cited by
Sorted by citations
Items 101–168 of 168
A Clinical Debate: What Is the Therapeutic Choice for Recurrent Graves’ Hyperthyroidism?
Abdi, H., Zakavi, S. R., & Azizi, F. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.108876 · Cited by 2
Autoimmune Thyroid Disease (Flajani-Parry-Graves-von Basedow Disease): An Overview of Treatment
Vargas‐Uricoechea, H., Bonelo, A., Sierra-Torres, C. H., & Meza-Cabrera, I. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_9 · Cited by 2
Soomro, R., Campbell, N., Campbell, S. E., Lesniak, C., Sullivan, M., Ong, R. K. S., Cheng, J., & Hossain, M. (2019) · Clinical Case Reports and Reviews · doi:10.15761/ccrr.1000469 · Cited by 2
Shaikh, U. N., Ghoto, M., Dayo, A., Arain, M., & Khan, J. (2021) · PAFMJ · doi:10.51253/pafmj.v71i5.3682 · Cited by 2
Hyperthyroidism and Thyrotoxicosis
Fatourechi, V. (2022) · Springer eBooks · doi:10.1007/978-3-030-90684-9_1 · Cited by 2
Antithyroid drug-induced pancytopenia followed by acute lymphoblastic leukemia: A rare case
Nehara, H. R., Gupta, B., Parmar, S., Kumar, V., Sihag, D., & Beniwal, S. (2020) · Thyroid Research and Practice · doi:10.4103/trp.trp_45_20 · Cited by 2
Letter to the Editor: “Our Response to COVID-19 as Endocrinologists and Diabetologists”
Kobaly, K. N., Mandel, S. J., Cappola, A. R., & Kim, C. S. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa212 · Cited by 2
Patrones de práctica clínica en la enfermedad de Graves en Colombia
Perdomo, D. F. S., Builes-Montaño, C. E., & Gómez, J. R. M. (2021) · Revista Colombiana de Endocrinología Diabetes & Metabolismo · doi:10.53853/encr.8.2.709 · Cited by 1
Feline pancytopenia: a review of causes, investigation and treatment
Parton, S., & Titmarsh, H. F. (2022) · Companion animal · doi:10.12968/coan.2021.0084 · Cited by 1
Racing Heart Under Stormy Skies: A Journey From Agranulocytosis to Thyroid Storm
Tan, J., Wong, M. V., Bernard, D. M. A., & Foo, S. H. (2026) · Cureus · doi:10.7759/cureus.106197 · Cited by 1
Pancytopenia Secondary To Autoimmune Vitamin B12 Deficiency In Graves Disease
Rodriguez, V., Gonzales, K. M., Iqbal, A. M., Arbelo‐Ramos, N., Wyatt, K. D., Lteif, A. N., & Castro, M. R. (2020) · AACE Clinical Case Reports · doi:10.4158/accr-2020-0055 · Cited by 2
Therapeutic plasma exchange for Graves’ disease in pregnancy
Lumchee, M., Yue, M., Laurie, J. G., & Morton, A. (2021) · Obstetric Medicine · doi:10.1177/1753495x211031328 · Cited by 1
Thyroid Hormones, Iodine and Iodides, and Antithyroid Drugs
Ethredge, H., Najafabadi, I. K., Deshmukh, R. R., Singh, A., & Mody, V. V. (2017) · Side effects of drugs annual · doi:10.1016/bs.seda.2017.06.017 · Cited by 1
Fadlalbari, G. F., Hassan, S. S., Abdalla, A. T., Abusamra, S. O., Abdalrhman, A. M., & Abdullah, M. A. (2022) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000527187 · Cited by 1
Sepsis-induced Pancytopenia in an Adolescent Girl with Thyroid Storm: A Case Report
Zhou, Q., Zhang, L., Fu, Q.-X., Zou, C., & Liu, H. (2023) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2023.2022-10-3 · Cited by 1
Fredette, M. E., Pillai, S. S., Ibrahim, O., Kochhar, M., Cotton, T. M., Rogo, T. O., Scheffler, M. D., & Bauer, A. J. (2024) · Hormone Research in Paediatrics · doi:10.1159/000536508 · Cited by 1
Hyperthyroidism crisis and complex pancytopenia: A case report.
Lei, X., Leng, W., Long, M., Xie, L., & Chen, L. (2024) · PubMed Central · doi:10.11817/j.issn.1672-7347.2024.240372 · Cited by 1
Minimal methimazole exposure-induced fatal pancytopenia
Au, X. Y., Kapsner, P., Shrestha, N., & Schade, D. S. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-261106 · Cited by 1
Kim, K. J., Song, E., Kim, M., Kwon, H., Ku, E. J., Kwon, H. W., Yoon, J. H., Lee, E. K., Lee, W. W., Park, Y. J., et al. (2025) · International Journal of Thyroidology · doi:10.11106/ijt.2025.18.1.65 · Cited by 1
Agranulocitosis inducida por metimazol en pacientes con enfermedad de Graves
Manrique-Hurtado, H., & Pinto-Valdivia, M. (2013) · Revista Médica Herediana · doi:10.20453/rmh.v24i2.592 · Cited by 1
Can propylthiouracil induce autoimmune-related immunotoxicity?
Bajkin, I. A., Golubović, S., Ičin, T., Stepanović, K., & Ilić, T. (2021) · Vojnosanitetski pregled · doi:10.2298/vsp210429067b · Cited by 1
[Adverse reactions of methimazole in children with hyperthyroidism].
Zhou, X., & Xin, Y. (2022) · PubMed Central · doi:10.7499/j.issn.1008-8830.2205022 · Cited by 2
Bolton, W. D., & Perkins, J. M. (2018) · Springer eBooks · doi:10.1007/978-3-319-99079-8_7 · Cited by 1
Do Gaps in Thionamide Treatment Accelerate the Onset of Agranulocytosis?
Spaulding, S. W. (2014) · Clinical Thyroidology · doi:10.1089/ct.2014;26.47-49
Carbimazole Induced Aplastic Anaemia
Zachariah, A., & Singh, S. (2015) · University journal of medicine and medical specialities
A Case of Graves’ Disease with Antithyroid Drug-induced Pancytopenia
Ono, M., Kasuga, Y., Harada, M., & Iesato, A. (2012) · 信州医学雑誌 · doi:10.11441/shinshumedj.60.201
Bartalena, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_17
The Role of Medical Management for Nodular Hyperthyroidism
Ycaza, A. E. E. D., & Stan, M. N. (2017) · Springer eBooks · doi:10.1007/978-3-319-43618-0_8
Asphyxia Following Complete Thyrodiectomy in a Patient with Relapsed Grave’s Disease
Wu, H. Y., & Wu, M. (2017) · Journal of Thyroid Disorders & Therapy · doi:10.4172/2167-7948.1000220
Pancytopenia in an untreated patient with toxic multinodular goiter
Ylli, A., Hoxha, V., Çela, E., Doracaj, D., Vyshka, G., & Çakërri, L. (2018) · European Journal of Medical Case Reports · doi:10.24911/ejmcr/173-1534869022
A Case of Graves’ Disease with Rare Complication of Carbimazole Induced Pancytopenia
Suryanarayana, K. (2020) · International Journal of Contemporary Medical Research [IJCMR] · doi:10.21276/ijcmr.2020.7.2.43
Hémorragie intra-alvéolaire induite par le propylthiouracil
Desmercières, J., Ribi, C., Azarnoush, K., Liaudet, L., Matter, M., & Ribordy, V. (2020) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2020.03.005
Prevalence of Neutropenia in Hyperthyroidism and Its Response to Hyperthyroidism Treatment
Samuels, M. H. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.468-470
Methimazole Is Associated with An Increased Risk for Acute Pancreatitis, but the Risk Is Very Small
Toft, D. J. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.74-76
Pancitopenia inducida por enfermedad de Graves en un paciente con tormenta tiroidea: reporte de caso
Medina-Jasso, J. J. (2021) · Revista Mexicana de Endocrinología Metabolismo y Nutrición · doi:10.24875/rme.20000073
Fadlalbari, G. F., Hassan, S. S., Abdallah, A. T., Abusamra, S. O., Abdalrhman, A. M., & Abdullah, M. A. (2021) · Research Square · doi:10.21203/rs.3.rs-792497/v1
Antithyroid drug therapy for Graves’ disease
Shin, S. M., & Yi, K. H. (2021) · Journal of Korean Medical Association · doi:10.5124/jkma.2021.64.10.690
Saran, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98686 · Cited by 1
Antithyroid Drugs for Thyrotoxicosis
Bartalena, L. (2022) · doi:10.1093/med/9780198870197.003.0059
Newman, S. K., & Davies, T. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00120-1
Bartalena, L. (2016) · Endocrinology · doi:10.1007/978-3-319-29195-6_17-1
Chng, C. L. (2018) · Springer eBooks · doi:10.1007/978-981-10-1124-5_2
Neutropenia febril inducida por metimazol
Baccelli, A., Sugo, V., & Perendones, M. (2022) · Revista Uruguaya de Medicina Interna · doi:10.26445/07.01.5
Woman With Fatigue and Weight Loss
Holmes, T., Abramczyk, R., Shaffer, C., Berger, M., Gibbons, R. C., & Costantino, T. G. (2022) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.11.010
Agranulocitosis inducida por metimazol en pacientes con enfermedad de Graves
Manrique-Hurtado, H., & Pinto-Valdivia, M. (2013) · Revista Médica Herediana · doi:10.20453/rnp.2013.592
Tionamide Agranulocytosis, A Complication Fearednot to Forget
Calvo, C. P. (2021) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2021.14.001994
Agranulocitosis inducida por metimazol en pacientes con enfermedad de Graves
Manrique-Hurtado, H., & Pinto-Valdivia, M. (2013) · Revista Médica Herediana · doi:10.20453/rmh.2013.592
(2015) · Elsevier eBooks · doi:10.1016/b978-0-444-53717-1.01537-7
Maheshwari, R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90314
Radionuclide Therapy in Benign Thyroid Diseases: Graves’ Disease
Araz, M., & Özkan, E. (2022) · Springer eBooks · doi:10.1007/978-3-030-97220-2_5
Matos, I. D. A. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2022.tde-02122022-154640
Manejo de la enfermedad tiroídea en el embarazo y puerperio
Paula Vergara, U., Verónica Araya, Q., Sepúlveda-Martínez, Á., & Parra-Cordero, M. (2019) · Revista Hospital Clínico Universidad de Chile · doi:10.5354/2735-7996.2019.70053
Management of thyroid crisis in a patient with febrile neutropenia
Gotera, W., Sugiharto, S., & Nugraha, I. B. A. (2023) · Intisari Sains Medis · doi:10.15562/ism.v14i1.1577
He, Y.-Y., Ma, P., Luo, Y., Gong, X.-J., Gao, J.-Y., Sun, Y., Chen, P., Zhang, S.-Y., Tian, Y., Shi, B., et al. (2023) · Experimental and clinical endocrinology & diabetes · doi:10.1055/a-2206-2242
Custer, M. K., Kidd, T., Ducker, K., & Lall, R. (2024) · Cureus · doi:10.7759/cureus.58535
Anemia aplásica inducida por metimazol: presentación de caso
Burbano, J. D. O., Idrobo, B. V. F., Correa, M., Muñoz, E. N., & Palechor, J. I. L. (2024) · Revista Ciencias de la Salud · doi:10.12804/revistas.urosario.edu.co/revsalud/a.12105
Moreno, M. A. M., Freja, A. G., Gómez, D., Zambrano, M. P. G., & Hernández, E. F. M. (2025) · Revista Colombiana de Hematología y Oncología · doi:10.51643/22562915.752
Lu, Y., Zhong, R., Shi, W., Zhou, D., Ran, Y., Yang, Q., Xu, D., Lin, H., Yao, L., Liao, S., et al. (2025) · medRxiv · doi:10.64898/2025.12.28.25343112
Selim, S., Tanni, A. Z., Afsana, F., Rahman, M. A., Mohiuddin, S. M., Mahjabeen, S., Rahman, M. H., Rahman, S. I., Saifuddin, M., Ferdous, C., et al. (2026) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_45_25
Ghandora, H., Alzahrani, M. K., Alsharif, R. L., Zahrani, H. A., Garni, M. A., & Jambi, H. (2026) · Frontiers in Pediatrics · doi:10.3389/fped.2026.1803842
Mossavarali, S., Vaezi, A., Sarvi, D. G., Mirdamadi, N., Mohseni, S., & Sani, M. P. (2026) · Research Square · doi:10.21203/rs.3.rs-9661309/v1
Ma, L., Ke, S., Huang, P., Chen, Y., Lin, Q., Lin, M., He, G., Zou, L., Chen, X., Liu, X., et al. (2026) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-026-04138-z
Tang, S., Zhang, F., Zhu, W., Yang, M., Gong, M., Dang, P., Jiang, R., Lu, H., Xin, Y., & Teng, X. (2026) · Thyroid · doi:10.1177/10507256261472376
Methimazole-Induced Severe Agranulocytosis Treated With High-Dose G-CSF
Shah, S. H., Mathur, D., Shah, S., & Bao, G. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.08.015
Паневин, Т. С., & Zotkin, E. G. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2026-349
Luo, Y., Fan, X., Yang, Q., Liu, H., Liu, Y., Wang, Y., Hui, G., Bingyin, S., Zhang, B., & Yayi, H. (2026) · Endocrine · doi:10.1007/s12020-026-04791-5
Metadata
- Authors
- Watanabe, N., Narimatsu, H., Noh, J. Y., Yamaguchi, T., Kobayashi, K., Kami, M., Kunii, Y., Mukasa, K., Ito, K., & Ito, K.
- Affiliations
- Ito Hospital (JP)
- Yamagata University (JP)
- Tohoku University (JP)
- JR Tokyo General Hospital (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Corresponding author
- Noh, Jaeduk Yoshimura
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2012-01
- Volume
- 97
- Issue
- 1
- Pages
- E49-E53
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2143907782
- Cited by
- 167
- References
- 19
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 12 · 2022: 15 · 2021: 12 · 2020: 21 · 2019: 8 · 2018: 11 · 2017: 14 · 2016: 11 · 2015: 9 · 2014: 10 · 2013: 9 · 2012: 4
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Blood disorders and treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
- Keywords
- antithyroid drugs, agranulocytosis, pancytopenia, hematopoietic damage, Graves' disease, methimazole, propylthiouracil, drug-induced neutropenia, granulocyte colony-stimulating factor, infectious complications, risk factors
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Agranulocytosis, Child, Female, Graves Disease, Hematopoiesis, Humans, Japan, Male, Methimazole, Middle Aged, Pancytopenia, Propylthiouracil, Retrospective Studies, Antithyroid Agents, Tokyo, Cohort Studies, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
